Chilvana Patel, MD is hosting a case-based panel discussion titled "Evolving Therapeutic Horizons in Myasthenia Gravis: Expert Perspectives on Targeted Therapies - Part 1." She will engage with renowned neuromuscular specialists—Pushpa Narayanaswami, MD, Nicholas Silvestri, MD, and Kelly Gwathmey, MD—to explore real-world cases and discuss the latest advances in targeted treatment options for Myasthenia Gravis.

Have you ever experienced tingling after running a marathon? Is marathon running good for your nerves? Tune in to this episode and listen to Drs. Rubin and Shahrizaila discuss an unusual case to help you decide whether or not to take up running.

In this episode, Dr. Nadia Khalil interviews Dr. Nathaniel Robbins, the Director of the Autonomic and Small Fiber Neuropathy program at Mass General Brigham, on POTS. In this episode, they review the diagnostic criteria, clinical presentation, differential diagnosis, adjunctive testing, and management.

Do you know what neuromuscular condition Spock from Star Trek may have had? Tune in to this Lessons from the Lab to learn!

In this AANEM podcast, Chilvana Patel, MD, interviews Devin Rubin, MD, and Nortina Shahrizaila, PhD, about global disparities in EMG and nerve conduction study training. They discuss challenges such as inconsistent educational program standards, limited resources, and lack of mentorship, especially in developing countries. This podcast covers the current efforts to improve access to hands-on training and standardized education.

Dr. Kelly Gwathmey interviews Dr. Corey Bacher from the University of Toronto, Dr. Charles Kassardjian from the University of Toronto, both in Toronto, Ontario, Canada. We also have Dr. Ruple Laughlin from the Mayo Clinic in Rochester, Minnesota, and Dr. Puspha Narayanswami from Beth Israel Deaconess Medical Center in Boston, Massachusetts. They will all be discussing recommendations for monitoring and managing glucocorticoid related systemic complications from the recently published: “International Consensus Guidance for the Management of Glucocorticoid Related Complications in Neuromuscular Disease."

This AANEM podcast features Dr. Joome Suh, a neurologist and neuromuscular specialist at Brigham and Women's Hospital, interviewed by neuromuscular fellow Dr. Nadia Khalil. They discuss HMG-CoA reductase immune-mediated necrotizing myopathy (HMGCR IMNM), a rare autoimmune muscle disease often associated with statin use. The discussion covers clinical presentation, epidemiologic considerations, histopathologic findings, and treatment approaches, with special focus on Dr. Suh’s recent research published in Muscle and Nerve with co-author Dr. Anthony Amato. Their study found that patients receiving maintenance IVIG as part of their regimen were more likely to have a normal CK at 6 months and the daily prednisone-equivalent was lower. A sub-group analysis suggested IVIG as monotherapy is effective.

How did you fare on your March Madness brackets? Did you win your EMG lab pool? Did you pick any upsets? Tune in and you will be sure to win this Lessons from the Lab March Madness bracket. It’s full of surprises and successes, and you won’t be “upset".

In this podcast, host Carrie Ford, CNCT, R.NCS.T., interviews 4 nerve conduction technologists: Candy Dolan, CNCT, R.NCS.T, R.EEGT, Pati Ramsey, CNCT, R.NCS.T, Nicole Wiley, CNCT, and Nathaniel Dickey, CNCT.
They discuss how AANEM transformed their field by establishing the Certified Nerve Conduction Technologist (CNCT) credential in 2011. The technologists share insights about AANEM membership benefits, certification challenges, employer support and offer advice to newcomers on mentorship and continuous learning. All emphasize the importance of certification and community involvement in maintaining professional standards.

The podcast explores the AANEM Training Program Partnership (TPP), an educational resource designed for neurology and PM&R training programs. The discussion features current neuromuscular fellows, Sukhraj Gill & Praveen Attele, along with hosts Bhaskar Roy (an associate professor at Yale) and Carrie Ford (a technologist at University of Utah).